Covidien (COV) Tops Q3 EPS by 6c
Tweet
Share
E-mailGet Alerts COV Hot Sheet
Price: $106.71 --0%
Financial Fact:
Other (expense) income, net: -20M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Other (expense) income, net: -20M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Covidien (NYSE: COV) reported Q3 EPS of $1.01, $0.06 better than the analyst estimate of $0.95. Revenue for the quarter came in at $2.93 billion versus the consensus estimate of $2.86 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Covalon Announces Conference Call to Discuss Third Quarter Fiscal 2026 Results
- Analog Devices (ADI) Tops Q3 EPS by 11c, Beats on Revenue; Offers Q4 Guidance
- ATRenew Inc (RERE) Tops Q2 EPS by 8c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
